Search results for "Heart Failure"
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016
Managing medications in patients with heart failure
Internists can provide a medical home to patients with heart failure so that medications and supplements are regularly assessed and managed, according to experts.
https://immattersacp.org/archives/2017/02/medications.htm
1 Feb 2017
Effects of heart failure therapies on quality of life compared
Sacubitril/valsartan may improve limitations in physical and social activities that are important to patients with heart failure, researchers noted.
https://immattersacp.org/weekly/archives/2018/04/10/1.htm
10 Apr 2018
CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care
A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016
A living guideline for depression treatment
ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023
Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes
Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016
Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
Among other recommendations, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or an angiotensin receptor-neprilysin inhibitor, along with a beta-blocker and an aldosterone antagonist, is the new recommended therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2016/05/24/2.htm
24 May 2016
Details on COVID-19 treatments authorized for outpatients
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/03/details-on-covid-19-treatments-authorized-for-outpatients.htm
1 Mar 2022
Medical therapy often not tried before ICDs in heart failure patients
Results of a trial suggest that at least some patients with heart failure are receiving ICDs needlessly and highlight the treatment gap between real-world management of heart failure with reduced ejection fraction and opportunities to improve care.
https://immattersacp.org/weekly/archives/2016/03/08/2.htm
8 Mar 2016